The data verified that CDN inhibited migration, invasion and EMT of CRC cells as well as lung metastasis through targeting ADRB2, manifesting that CDN may suppress metastasis of CRC as a molecular targeted therapeutic drug. The gene discussed is NT5C; the disease is colorectal carcinoma.